AvalehtB1AX34 • BVMF
add
Baxter International Inc Bdr
Viimane sulgemishind
81,75 R$
Aasta vahemik
80,31 R$ - 108,85 R$
Turuväärtus
15,39 mld USD
Keskmine maht
11,00
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | märts 2025info | Y/Y muutus |
|---|---|---|
Käive | 2,62 mld | 5,42% |
Põhitegevusega seonduv kulu | 732,00 mln | −9,85% |
Puhastulu | 126,00 mln | 240,54% |
Puhaskasumimarginaal | 4,80 | 222,15% |
Puhaskasum aktsia kohta | 0,55 | −15,38% |
EBITDA | 503,00 mln | 16,17% |
Tõhus maksumäär | 2 233,33% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | märts 2025info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 2,29 mld | −24,19% |
Kogu vara | 21,30 mld | −23,33% |
Kõik kohustused | 14,25 mld | −27,12% |
Kogu omakapital | 7,05 mld | — |
Emiteeritud aktsiate arv | 513,17 mln | — |
Hinna ja väärtuse suhe P/B | 5,92 | — |
Varade tasuvus | 2,72% | — |
Kapitali tasuvus | 3,38% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | märts 2025info | Y/Y muutus |
|---|---|---|
Puhastulu | 126,00 mln | 240,54% |
Põhitegevuse rahakäive | −193,00 mln | −218,40% |
Investeeringute raha | 3,26 mld | 2 066,87% |
Finantseerimise raha | −3,23 mld | −2 204,29% |
Raha ja raha ekvivalentide muutus | −118,00 mln | 29,76% |
Tasuta rahavoog | 1,73 mld | 395,14% |
Teave
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Tegevjuht
Asutatud
1931
Veebisait
Töötajate arv
38 000
